Psylo
Latest round
- Seed
Last raised
- May 2024
Total raised
- $10M
Investors
- 10
About Psylo
1 million in the capital. The Chief Scientific Officer, Samuel Banister, is formerly the team leader in medicinal chemistry at the Brain and Mind Centre at the University of Sydney. The company focuses on psychedelic-assisted therapy using psilocybin, which is being evaluated as a potential treatment for severe mental illness. It is developing a shorter-acting version of psilocybin, which normally takes effect for 6-8 hours in duration.
Who invested in Psylo
10 investors across 2 rounds
See all investors in Psylo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Psylo
Who invested in Psylo?
Psylo has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Psylo raised?
Psylo has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Psylo last raise money?
Psylo's most recent round on record is a Seed, in May 2024.
What does Psylo do?
Psylo is a biotechnology company.
Where is Psylo headquartered?
Psylo is headquartered in Sydney, Australia.
Which VCs invest in companies like Psylo?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Psylo's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Psylo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.